All articles by Scarlett Evans

  1. Potential drug target for anti-obesity treatment discovered

    Researchers have determined the molecular structure of the neuropeptide Y1 receptor (Y1R), a protein of central importance in food intake,…
    Read More…

    19 Apr
  2. Novartis to invest $100m in antimalarials over the next five years

    Novartis has announced plans to invest more than $100m into the research and development of next-generation antimalarial treatments over the…
    Read More…

    19 Apr
  3. FDA approves Opdivo/Yervoy combo treatment for kidney cancer

    The US Drug and Food Administration (FDA) has approved a combination therapy using Opdivo (nivolumab) and Yervoy (ipilimumab) as a…
    Read More…

    18 Apr
  4. AstraZeneca announces OS data from breast cancer treatment Lynparza

    AstraZeneca and Merck have announced overall survival (OS) data from Phase III trial OlympiAD examining Lynparza (olaparib) as a treatment…
    Read More…

    18 Apr
  5. Herantis reports positive interim data for gene therapy Lymfactin

    Herantis Pharmaceuticals has announced positive results from a safety evaluation of its Phase I clinical trial of Lymfactin, the company’s…
    Read More…

    17 Apr
  6. Ketamine nasal spray found to have fast-acting effect on depression

    Researchers at the Yale School of Medicine and Janssen Research and Development have developed a fast-acting nasal spray formulation of…
    Read More…

    16 Apr
  7. AstraZeneca reports post-progression data for lung cancer drug Tagrisso

    Anglo-Swedish biopharma AstraZeneca has reported post-progression outcome data from its Phase III FLAURA trial, investigating the efficacy and safety of…
    Read More…

    16 Apr
  8. Positive Phase I data from Rafael leukaemia combo treatment

    Rafael Pharmaceuticals has published Phase I data from a study of its lead compound CPI-613 in combination with high-dose cytarabine…
    Read More…

    13 Apr
  9. Generated mouse model offers possibility of personalised cancer treatment

    Researchers from the Seve Ballesteros Foundation-CNIO Brain Tumour Group at the Spanish National Cancer Research Centre (CNIO) have created a…
    Read More…

    13 Apr
  10. Researchers test new combo treatment for therapy-resistant melanoma

    Researchers at the Wistar Institute have found a new combination treatment to effectively target a previously unknown vulnerability in NRAS…
    Read More…

    13 Apr